Details of the Drug
General Information of Drug (ID: DMTOUCL)
Drug Name |
JWH-249
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
JWH-249; 1-pentyl-3-(2-bromophenylacetyl)indole; 864445-60-3; UNII-H988KQV4U9; H988KQV4U9; CHEMBL363471; 2-(2-bromophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; DTXSID30658735; JWH 249; CGQRVOHECAULLB-UHFFFAOYSA-N; ZINC28461369; BDBM50170337; 2-(2-Bromo-phenyl)-1-(1-pentyl-1H-indol-3-yl)-ethanone; Ethanone, 2-(2-bromophenyl)-1-(1-pentyl-1H-indol-3-yl)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 384.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 5.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 7 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||